BioLargo, Inc.
BLGOOTCBasic Materials● Active
$0.14
$-0.01(-6.35%)
Market Cap$44923620
P/E Ratio—
52W High$0.23
52W Low$0.1
BioLargo, Inc. (BLGO) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BLGO · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 15, 2026EPS Actual
-$0.01
Est. -$0.01 · +0.0%
Revenue
$0.00B
Est. $0.00B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 15, 2026
After Market Close
✓ 3-Quarter EPS Beat Streak
BLGO reports quarterly as a OTC-listed Chemicals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 18, 2026 | -$0.01 | — | — | — | $0.00B | — |
| — Q2 FY2026 | May 15, 2026 | -$0.01 | -$0.01 | +0.0% | $0.00B | $0.00B | +0.0% |
| — Q1 FY2026 | Mar 4, 2026 | -$0.01 | -$0.01 | +0.0% | $0.00B | $0.00B | -49.7% |
| — Q4 FY2025 | Nov 14, 2025 | — | -$0.02 | — | $0.00B | $0.00B | -60.6% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.01 | -$0.00 | +60.7% | $0.00B | $0.00B | -2.4% |
| — Q2 FY2025 | May 15, 2025 | — | -$0.00 | — | $0.00B | $0.00B | -3.6% |
| — Q1 FY2025 | Mar 31, 2025 | — | -$0.01 | — | $0.00B | $0.01B | -34.7% |
| — Q4 FY2024 | Nov 14, 2024 | — | -$0.00 | — | $0.00B | $0.01B | -13.1% |
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 15, 2026
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.00B
Q1 FY2026
Mar 4, 2026
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2025
Nov 14, 2025
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.00
EPS Est.
-$0.01
EPS Surpr.
+60.7%
Revenue
$0.00B
Q2 FY2025
May 15, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 31, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q3 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 15, 2026 | +0.0% | $0.13 | $0.13 | -0.34% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +0.0% | $0.18 | $0.18 | +1.31% |
| — Q4 FY2025 | Nov 14, 2025 | — | $0.17 | $0.16 | -7.92% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +60.7% | $0.18 | $0.18 | +0.00% |
| — Q2 FY2025 | May 15, 2025 | — | $0.24 | $0.24 | -1.68% |
| — Q1 FY2025 | Mar 31, 2025 | — | $0.28 | $0.28 | -2.12% |
| — Q4 FY2024 | Nov 14, 2024 | — | $0.20 | $0.20 | +1.04% |
| — Q3 FY2024 | Aug 14, 2024 | — | $0.24 | $0.24 | -1.26% |
Q2 FY2026-0.34%
Report Date
May 15, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.13
Price After
$0.13
Q1 FY2026+1.31%
Report Date
Mar 4, 2026
EPS Beat/Miss
+0.0%
Price Before
$0.18
Price After
$0.18
Q4 FY2025-7.92%
Report Date
Nov 14, 2025
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.16
Q3 FY2025+0.00%
Report Date
Aug 14, 2025
EPS Beat/Miss
+60.7%
Price Before
$0.18
Price After
$0.18
Q2 FY2025-1.68%
Report Date
May 15, 2025
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.24
Q1 FY2025-2.12%
Report Date
Mar 31, 2025
EPS Beat/Miss
—
Price Before
$0.28
Price After
$0.28
Q4 FY2024+1.04%
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.20
Q3 FY2024-1.26%
Report Date
Aug 14, 2024
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.24
Avg Beat Reaction+0.32%
Beat Rate3 / 8 quarters
Largest Move-7.92% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BLGO ends December
BioLargo, Inc. (BLGO) most recently reported earnings on May 15, 2026 for Q2 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of $-0.01). BLGO has beaten EPS estimates for 3 consecutive quarters. The next BLGO earnings date is expected around September 1, 2026.
Each quarter, investors track BLGO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BLGO revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BLGO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BLGO earnings · 4 questionsBioLargo, Inc.'s next earnings report is expected around September 1, 2026. BLGO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BLGO historically reports after market close (AMC).
BLGO earnings datewhen is BLGO earningsBLGO next earnings datewhen does BLGO report earningsBLGO earnings calendar
▸ Source: FMP · BioLargo, Inc. SEC filings · US GAAP · BioLargo, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026